CASGEVY

FDA Approves Casgevy for Young Children With Sickle Cell Disease

SILVER SPRING, Maryland, July 1, 2026 The U.S. Food and Drug Administration (FDA) has granted supplemental approval for Casgevy...

By cGxPwire Editor
July 6, 2026

Pharma

Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children

BOSTON, July 1, 2026 Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the expanded...

By cGxPwire Editor
July 2, 2026

.Clinical

Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics

BOSTON, June 11, 2026 Vertex Pharmaceuticals announced new Phase 3 clinical data demonstrating the potential of CASGEVY® (exagamglogene autotemcel)...

By cGxPwire Editor
June 12, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

FDA Approves Casgevy for Young Children With Sickle Cell Disease

Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children

Vertex Reports Successful Phase 3 CASGEVY Outcomes in Pediatrics